Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice

被引:16
|
作者
Narasimhulu, Chandrakala Aluganti [1 ]
Mitra, Connie [1 ]
Bhardwaj, Deepshikha [1 ]
Burge, Kathryn Young [1 ]
Parthasarathy, Sampath [1 ]
机构
[1] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA
关键词
Atherosclerosis; blood-brain barrier; neurological markers; PON1; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; MOUSE MODEL; ATHEROSCLEROSIS; POLYMORPHISMS; PATHOGENESIS; ASSOCIATION; MACROPHAGES; PLAQUE; BRAIN;
D O I
10.3233/JAD-180883
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) is a neurodegenerative disorder associated with aging. Cardiovascular risk factors like hypertension and atherosclerosis increase the risk for AD. Polymorphic alleles of apolipoprotein E (ApoE) are one of the main genetic determinants of AD. Objective: Mice, double-knockout (DKO) for ApoE (major cholesterol carrier in brain) and PON1 (paroxonase1, reduces oxidative stress), showed severe age-dependent atherosclerosis of the arteries carrying blood to the brain even on normal diet. This prompted us to investigate the possibility of an AD pathology resulting from the deficiency of ApoE and the induction of oxidative stress. Methods: Atherosclerotic lesions were quantified by ImageJ. The brain hippocampus of young and old ApoE-PON1 DKO mice and control mice were harvested. RT-PCR analysis was performed for mRNA levels of AD specific markers. Blood levels of S100 calcium-binding protein B (S100B) protein were measured by ELISA. H&E as well as immunostaining was performed to detect amyloid-beta (A beta) plaques and neurofibrillary tangles (NFTs) in brain tissues. Evans blue dye was used to evaluate the vascular permeability and blood-brain barrier (BBB) dysfunction. Results: Results showed that the older DKO mice had severe carotid atherosclerosis, increased mRNA levels of AD markers in brain tissue, and elevated levels of serum S100B protein. Immunological staining confirmed the characteristics of AD. Ex-vivo imaging showed higher levels of Evans blue dye in the ApoE-PON1 DKO mice brain tissues, pointing toward impaired vasculature. Conclusion: Aged ApoE-PON1 DKO mice displaying AD specific markers along with A beta plaques, NFTs, and disrupted BBB suggests the animals are suffering from AD.
引用
收藏
页码:1353 / 1365
页数:13
相关论文
共 50 条
  • [31] Association of APOE alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease neuroimaging markers
    Kulminski, Alexander M.
    Jain-Washburn, Ethan
    Nazarian, Alireza
    Wilkins, Heather M.
    Veatch, Olivia
    Swerdlow, Russell H.
    Honea, Robyn A.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [32] APOE and BDNF as genetic risk markers for predicting the onset and development of cognitive deficits due to Alzheimer's disease
    Cechova, K.
    Chmatalova, Z.
    Matuskova, V
    Matoska, V
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (03) : 257 - 262
  • [33] APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer's disease mice
    Stephen, T. L.
    Breningstall, B.
    Suresh, S.
    McGill, C. J.
    Pike, C. J.
    JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)
  • [34] Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice
    Coornaert, Isabelle
    Puylaert, Pauline
    Marcasolli, Giullia
    Grootaert, Mandy O. J.
    Vandenabeele, Peter
    De Meyer, Guido R. Y.
    Martinet, Wim
    ATHEROSCLEROSIS, 2021, 322 : 51 - 60
  • [35] A meta-analysis of Alzheimer's disease's relationship with human ApoE gene variants
    Xu, Xiru
    Zhang, Biao
    Wang, Xu
    Zhang, Qing
    Wu, Xiang
    Zhang, Jing
    Bai, Yu
    Gu, Xiaoqun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 9974 - 9982
  • [36] Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Martiskainen, Henna
    Haapasalo, Annakaisa
    Kurkinen, Kaisa M. A.
    Pihlajamaki, Jussi
    Soininen, Hilkka
    Hiltunen, Mikko
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 781 - 794
  • [37] APOE and Alzheimer's Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
    Brandon, Jason A.
    Farmer, Brandon C.
    Williams, Holden C.
    Johnson, Lance A.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [38] Genetic and regulatory architecture of Alzheimer's disease in the APOE region
    Kulminski, Alexander M.
    Shu, Leonardo
    Loika, Yury
    He, Liang
    Nazarian, Alireza
    Arbeev, Konstantin
    Ukraintseva, Svetlana
    Yashin, Anatoliy
    Culminskaya, Irina
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [39] Age, APOE and sex: Triad of risk of Alzheimer's disease
    Riedel, Brandalyn C.
    Thompson, Paul M.
    Brinton, Roberta Diaz
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 160 : 134 - 147
  • [40] ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP/PS-1 mice
    Chen, Mu-Han
    Liu, Xin-Ze
    Qu, Xiu-Wu
    Guo, Rui-Bo
    Zhang, Lu
    Kong, Liang
    Yu, Yang
    Liu, Yang
    Zang, Juan
    Li, Xiu-Ying
    Li, Xue-Tao
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023, 49 (09) : 559 - 571